PharmExec
CONTINUE TO SITE >

OR WAIT 15 SECS

Thomas Unger

Thomas Unger, PhD, MBA, is an Associate Director at Arthur D. Little.

Articles

Managing the 3 Fronts of the Drug Pricing Conundrum: Policy, Creativity, Collaboration

The impacts of disruptive curative therapies and advances in the future of health will be profound. To be best positioned for success, healthcare systems under continuous cost pressure must address three key areas, writes Thomas Unger.